The Caribbean region has taken a transformative step to address one of the globe’s most pressing public health crises, with the Caribbean Public Health Agency (CARPHA) officially opening a new Antimicrobial Resistance (AMR) Regional Reference Laboratory on the island of Jamaica. This cutting-edge facility marks the final piece of a years-long effort to upgrade the region’s interconnected laboratory referral network, unlocking expanded access to life-saving specialized testing for all 26 of CARPHA’s member states across the Caribbean.
Global public health authorities have long ranked antimicrobial resistance — the phenomenon through which bacteria, viruses and other pathogens evolve to resist existing drug treatments — as among the most severe threats to global wellbeing. Leading projections warn that AMR could be responsible for as many as 10 million deaths annually worldwide by the middle of the century. For the Caribbean, the challenge has been amplified by longstanding systemic gaps: limited regional AMR surveillance infrastructure, consistent delays in pathogen diagnosis, uneven access to high-quality antimicrobial medications, and widespread overuse and misuse of antibiotics across both human healthcare and agricultural animal production.
Housed within CARPHA’s existing Medicines Quality Control and Surveillance Department, the new laboratory was formally inaugurated at a ceremony attended by key regional and international stakeholders. Officiating the opening were Jamaica’s Minister of Health and Wellness, Dr. Christopher Tufton, and CARPHA Executive Director Dr. Lisa Indar. Delegations from the British High Commission in Jamaica, the UK Health Security Agency (UKHSA), the UK Department of Health and Social Care, the Pan American Health Organization (PAHO), and multiple other partner organizations were also on hand to mark the milestone.
The facility’s development and operations are backed by funding from the Fleming Fund, delivered through the Caribbean Antimicrobial Resistance Alliance (CARA) with technical and policy support from UKHSA and the UK’s Department of Health and Social Care. Andrew Bowden, a representative of the British High Commission, confirmed the UK’s total investment in the project reaches at least £480,000, equal to roughly 105 million Jamaican dollars, which covered equipment procurement, facility refurbishment, and the formal establishment of the laboratory. This investment drastically boosts CARPHA’s capacity to detect, track, and respond to AMR outbreaks, while expanding access to advanced microbiology and clinical diagnostic services across the region.
The new Jamaican facility joins two existing regional AMR reference laboratories in Trinidad and Tobago and St. Lucia, forming a fully integrated, interconnected regional referral network. Officials project this unified system will cut down on testing turnaround times, dramatically improve the accuracy and scope of AMR surveillance, and enable far faster public health intervention when resistant pathogens are detected.
In remarks at the inauguration ceremony, Dr. Indar framed the launch as a watershed moment for Caribbean public health infrastructure. “Today’s landmark launch represents the successful completion of a major investment in the Caribbean’s public health infrastructure. Together, our laboratories in Trinidad and Tobago, Saint Lucia and Jamaica now form a fully integrated regional referral laboratory network, enabling us to provide faster, more equitable access to specialised diagnostic services for all 26 CARPHA Member States,” she said. “This is not simply an investment in laboratories—it is an investment in stronger surveillance, more effective outbreak response and a more resilient Regional Health System.”
Dr. Tufton highlighted that Jamaica has already advanced its own domestic AMR response through targeted action across four core pillars: expanded surveillance, improved infection prevention protocols, stronger antimicrobial stewardship programs, and widespread public education campaigns. He added that the new regional laboratory will strengthen Jamaica’s domestic efforts while supporting neighboring countries across the Caribbean.
CARPHA officials noted the opening of the facility builds on the agency’s broader Integrated AMR Programme, launched in 2025 to coordinate regional action against resistant pathogens. The milestone reinforces CARPHA’s core commitment to ensuring equitable access to high-quality diagnostic and laboratory services for all member states, while boosting overall regional health security through ongoing cross-border and international collaboration.